Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Two existing drugs may help treat COVID-19 by inhibiting a key viral protein.

Adding a second method to PROTACs could improve cancer treatment.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Baricitinib may effectively treat oral lichen planus.

PPAR activation can improve diabetic wound healing by enhancing blood vessel function.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The process effectively regenerates the Pd/C catalyst for finasteride synthesis.

Placenta extract may protect and improve liver health by reducing stress, inflammation, and cell death, and promoting regeneration.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

L-cystine, D-pantothenat, and miliacin together significantly boost keratinocyte growth and metabolism.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

4-octyl itaconate may prevent hearing loss caused by the drug cisplatin by activating certain cell protection pathways.

Lowering homocyst(e)ine levels can reverse skin and hair lightening by restoring enzyme activity needed for pigmentation.

A man developed skin issues from cancer medication, which improved with specific treatments.